首页> 外文期刊>Biology of blood and marrow transplantation: journal of the American Society for Blood and Marrow Transplantation >Neurocognitive Functioning in Adults Who Underwent Nonmyeloablative HLA-Matched Sibling Hematopoietic Stem Cell Transplant (SCT) for Sickle Cell Disease (SCD)

【24h】

Neurocognitive Functioning in Adults Who Underwent Nonmyeloablative HLA-Matched Sibling Hematopoietic Stem Cell Transplant (SCT) for Sickle Cell Disease (SCD)

机译：接受非清髓性HLA配对同胞造血干细胞移植（SCT）治疗镰状细胞病（SCD）的成年人的神经认知功能

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Biology of blood and marrow transplantation: journal of the American Society for Blood and Marrow Transplantation》 |2016年第1期|共1页
作者
Martin Staci; Abel Cristina B.; Wolters Pamela L.; Toledo-Tamula Mary Anne; Fitzhugh Courtney; Hsieh Matthew; Tisdale John F.;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类治疗学;
关键词

相似文献

外文文献
中文文献
专利

1. Neurocognitive Functioning in Adults Who Underwent Nonmyeloablative HLA-Matched Sibling Hematopoietic Stem Cell Transplant (SCT) for Sickle Cell Disease (SCD) [J] . Martin Staci, Abel Cristina B., Wolters Pamela L., Biology of blood and marrow transplantation: journal of the American Society for Blood and Marrow Transplantation . 2016,第3Suppla1期

机译：接受非清髓性HLA配对同胞造血干细胞移植（SCT）治疗镰状细胞病（SCD）的成年人的神经认知功能
2. Nonmyeloablative HLA-matched sibling allogeneic hematopoietic stem cell transplantation for severe sickle cell phenotype [J] . HsiehM.M., FitzhughC.D., WeitzelR.P., JAMA: the Journal of the American Medical Association . 2014,第1期

机译：非清髓HLA匹配的同种异体造血干细胞移植治疗严重的镰状细胞表型
3. PHARMACOKINETICS AND CLINICAL OUTCOMES OF INTRAVENOUS BUSULFAN ADMINISTERED TWICE DAILY DURING CONDITIONING IN PEDIATRIC RECIPIENTS PRIOR TO FAMILIAL HAPLOIDENTICAL(FHI) T-CELL DEPLETED (TCD) ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION (AlloHSCT) IN HIGH RISK SICKLE CELL DISEASE (SCD) [J] . Mehta Brinda, Klejmont Liana, Milone Michael, Pediatric blood & cancer . 2016,第Suppla1期

机译：患儿全亲肝病（TCD）异基因造血干细胞病（TCD）完全性干细胞病性干细胞病原发性干细胞病（PC）病史前，每日两次在儿科患者接受条件治疗期间，静脉bususfan不良反应的药代动力学和临床结果
4. HIGH DOSE THERAPY WITH AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION (HSCT) FOR PATIENTS WITH PRIMARY SYSTEMIC AMYLOIDOSIS (AL): AN ABMTR STUDY [C] . DH Vesole, W Perez, D Reece, International Symposium on Amyloidosis . 2005

机译：具有自体造血干细胞移植（HSCT）的高剂量治疗用于初级全身淀粉样蛋白症（AL）的患者：ABMTR研究
5. Ex vivo expansion of hematopoietic stem cells for use in nonmyeloablative transplantation. [D] . Bakovic, Silvia. 2007

机译：用于非清髓性移植的造血干细胞的体外扩增。
6. The impact of pre-existing HLA and red blood cell antibodies on transfusion support and engraftment in sickle cell disease after nonmyeloablative hematopoietic stem cell transplantation from HLA-matched sibling donors: A prospective single-center observational study [O] . Robert Sheppard Nickel, Willy A. Flegel, Sharon D. Adams, 2020

机译：HLA匹配的同胞供体非清髓性造血干细胞移植后既存的HLA和红细胞抗体对镰状细胞病的输血支持和移植的影响：一项前瞻性单中心观察性研究
7. The impact of pre-existing HLA and red blood cell antibodies on transfusion support and engraftment in sickle cell disease after nonmyeloablative hematopoietic stem cell transplantation from HLA-matched sibling donors: A prospective, single-center, observational study [O] . Robert Sheppard Nickel, Willy A. Flegel, Sharon D. Adams, 2020

机译：预先存在的HLA和红细胞抗体对来自HLA匹配兄弟供体的非植物造血干细胞移植后镰状细胞疾病输血载体和植入的影响：一项前瞻性，单中心，观测研究

获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

客服微信
服务号